Evidence map›Paper›PMID 18370982›Full record

Trial reportAcademic emergency medicine : official journal of the Society for Academic Emergency Medicine2008

Comparison of nebulized epinephrine to albuterol in bronchiolitis.

Paul Walsh, John Caldwell, Kemedy K McQuillan, Steven Friese, Dale Robbins, Stephen J Rothenberg

Open access · bronzeAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Bronchodilators for bronchiolitis.The Cochrane database of systematic reviews · 2014
    Pooled it
  2. Epinephrine for bronchiolitis.The Cochrane database of systematic reviews · 2011
    Pooled it
  3. Bronchiolitis.BMJ clinical evidence · 2011
    Pooled it
  4. Trial
  5. Trial
  6. Low-dose intrapulmonary drug delivery device for studies on next-generation therapeutics in mice.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  7. Article
  8. Article
  9. Even the Thinnest Salami Contains Some Meat.The western journal of emergency medicine · 2018
    Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Paul WalshDepartment of Emergency Medicine, Kern Medical Center, Bakersfield, CA, USA. yousentwhohome@gmail.com
John Caldwell
Kemedy K McQuillan
Steven Friese
Dale Robbins
Stephen J Rothenberg
University of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo compare the effect of nebulized racemic epinephrine to nebulized racemic albuterol on successful discharge from the emergency department (ED).

methodsChildren up to their 18th month of life presenting to two teaching hospital EDs with a clinical diagnosis of bronchiolitis who were ill enough to warrant treatment but did not need immediate intubation were eligible for this double-blind randomized controlled trial (RCT). Patients received either three doses of racemic albuterol or one dose of racemic epinephrine plus two saline nebulizers. Disposition was decided 2 hours after the first nebulizer. Successful discharge was defined as not requiring additional bronchodilators in the ED after study drug administration and not subsequently admitted within 72 hours. Adjusted relative risks (aRR) were estimated using the modified Poisson regression with successful discharge as the dependent variable and study drug and severity of illness as exposures. Secondary analysis was performed for patients aged less than 12 months and first presentation.

resultsThe authors analyzed 703 patients; 352 patients were given albuterol and 351 epinephrine. A total of 173 in the albuterol group and 160 in the epinephrine group were successfully discharged (crude RR = 1.08, 95% confidence interval [CI] = 0.92 to 1.26). When adjusted for severity of illness, patients who received albuterol were significantly more likely than patients receiving epinephrine to be successfully discharged (aRR = 1.18, 95% CI = 1.02 to 1.36). This was also true among those with first presentation and in those less than 12 months of age.

conclusionsIn children up to the 18th month of life, ED treatment of bronchiolitis with nebulized racemic albuterol led to more successful discharges than nebulized epinephrine.

Indexed as

Emergency Service, HospitalRacepinephrineAcute DiseaseAdministration, InhalationAlbuterolBronchiolitisBronchodilator AgentsDouble-Blind MethodEpinephrineFemaleHumansInfantMaleNebulizers and VaporizersSeverity of Illness IndexTreatment OutcomeAlbuterolBronchodilator AgentsEpinephrineRacepinephrine

Identifiers

PMID18370982
PMCPMC2613253
OpenAlexW2158919091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.